Definition of Cataplexy: Cataplexy is a sudden loss of muscle tone, sometimes associated with narcolepsy.
The following drugs and medications are in some way related to, or used in the treatment of Cataplexy. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Finastid may be available in the countries listed below.
Finasteride is reported as an ingredient of Finastid in the following countries:
International Drug Name Search
Dantrolène may be available in the countries listed below.
Dantrolène (DCF) is known as Dantrolene in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Mannit Fresenius may be available in the countries listed below.
Mannitol is reported as an ingredient of Mannit Fresenius in the following countries:
International Drug Name Search
Morantel Citrate may be available in the countries listed below.
Morantel Citrate (BANM) is also known as Morantel (Prop.INN)
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
Tifol may be available in the countries listed below.
Folic Acid sodium salt (a derivative of Folic Acid) is reported as an ingredient of Tifol in the following countries:
International Drug Name Search
Mébévérine Zydus may be available in the countries listed below.
Mebeverine hydrochloride (a derivative of Mebeverine) is reported as an ingredient of Mébévérine Zydus in the following countries:
International Drug Name Search
Kapril may be available in the countries listed below.
Captopril is reported as an ingredient of Kapril in the following countries:
International Drug Name Search
Generic Name: belimumab (be LIM ue mab)
Brand Names: Benlysta
Belimumab is a monoclonal antibody that affects the actions of the body's immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.
Belimumab is used in to treat active systemic lupus erythematosus (SLE) in adults.
Belimumab is not for use in people who have severe kidney problems caused by SLE, or have active SLE that affects the central nervous system (brain, nerves, and spinal cord).
Belimumab may also be used for other purposes not listed in this medication guide.
Before you receive belimumab, tell your doctor if you have an active or chronic infection, a history of cancer, or a history of depression or mental illness.
Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection. Do not receive a "live" vaccine within 30 days before or after you are treated with belimumab.
You may have thoughts about suicide while receiving belimumab, especially if you have a history of suicidal thoughts or actions. Report any new or worsening symptoms to your doctor, such as: depression, anxiety, mood or behavior changes, trouble sleeping, or thoughts about hurting yourself or others.
To make sure you can safely receive belimumab, tell your doctor if you have any of these other conditions:
an active or chronic infection;
a history of cancer; or
a history of depression or mental illness.
You may have thoughts about suicide while receiving belimumab, especially if you have a history of suicidal thoughts or actions.
Belimumab is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Belimumab must be given slowly, and the IV infusion can take about an hour to complete.
The first 3 doses of belimumab are given 2 weeks apart. Then the injections are given every 4 weeks. Your dosing schedule may be different. Follow your doctor's instructions.
Contact your doctor if you miss an appointment for your belimumab injection.
Avoid being near people who have colds, the flu, or other contagious illnesses.
new or worsening depression, anxiety, mood or behavior changes, trouble sleeping, or thoughts about hurting yourself or others;
chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling.
wheezing, chest tightness, trouble breathing; or
fever, chills, flu symptoms, night sweats, weight loss;
increased urination, pain or burning when you urinate;
cough with yellow or green mucus, stabbing chest pain, feeling short of breath;
swelling, pain, tenderness, or redness anywhere on your body; or
bloody diarrhea.
Less serious side effects may include:
nausea, diarrhea, stomach pain;
mild pain in your arms or legs; or
mild cold symptoms such as stuffy nose, sneezing, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Systemic Lupus Erythematosus:
10 mg/kg as an intravenous infusion only, over a period of 1 hour, at 2 week intervals for the first 3 doses and at 4 week intervals thereafter.
Consider administering premedication for prophylaxis against infusion reactions and hypersensitivity reactions.
Tell your doctor about all other medicines you use, especially:
cyclophosphamide (Cytoxan); or
drugs that weaken your immune system such as cancer medicine, steroids, and medicines to prevent rejection of a transplanted organ.
This list is not complete and other drugs may interact with belimumab. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: belimumab side effects (in more detail)
Monotrate may be available in the countries listed below.
Isosorbide Mononitrate is reported as an ingredient of Monotrate in the following countries:
International Drug Name Search
Coartem is a brand name of artemether/lumefantrine, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Coartem available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Coartem. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Isotic Azora may be available in the countries listed below.
Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Isotic Azora in the following countries:
Pheniramine maleate (a derivative of Pheniramine) is reported as an ingredient of Isotic Azora in the following countries:
International Drug Name Search
Sefanid may be available in the countries listed below.
Cefadroxil is reported as an ingredient of Sefanid in the following countries:
International Drug Name Search
Neofomiral may be available in the countries listed below.
Fluconazole is reported as an ingredient of Neofomiral in the following countries:
International Drug Name Search
Magnecyl-koffein brus may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Magnecyl-koffein brus in the following countries:
Caffeine is reported as an ingredient of Magnecyl-koffein brus in the following countries:
International Drug Name Search
